Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000028954Phase 4Recruiting
Phase 4 trial of dexmedetomidine in circadian rhythm sleep disorder (CRSD) (2 arms), sponsored by Union Hospital. Primary endpoints: Deep sleep quality score, Urinary dopamine concentration and 3 more. Started Jan 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000028954.